Michael Weller, MD
University of Zurich · UniversitaetsSpital Zurich - Department of Neurology, Zurich, Switzerland · Department of Neurology, University of Zurich, Switzerland
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Michael Weller, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 14:29 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07832123 · Safusidenib for Patients With Newly Diagnosed IDH1-mutant CNS WHO Grade 3 Oligodendroglioma and Astrocytoma - a Single Arm Phase II StudyUniversity of Zurich · not yet recruiting · Glioma : Oligodendroglioma or Astrocytoma · study chair
- Ph3NCT05522660 · Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung CancerETOP IBCSG Partners Foundation · recruiting · Non-Small Cell Lung Cancer, Melanoma · study chair
- N/ANCT02307604 · SPECTAbrain: Screening Patients With Brain Tumors for Efficient Clinical Trial AccessEuropean Organisation for Research and Treatment of Cancer - EORTC · withdrawn · Brain Neoplasms · study chair
- Ph3NCT00717210 · Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or TemozolomideNeuro-Oncology Working Group of the German Cancer Society · completed · Anaplastic Astrocytoma, Oligodendroglioma, Oligoastrocytoma · principal investigator
- Ph4NCT00571155 · Trial of Levetiracetam in Patients With Primary Brain Tumors and Symptomatic Seizures Who Undergo SurgeryUniversity Hospital Tuebingen · completed · Primary Brain Tumor, Epilepsy · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 14:29 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in non-small cell lung cancer.